Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer

Cancer Letters

Volumn 357, Issue 1, 2015, Pages 242-253

  Sun, Li ^a   Duan, Jiangman ^a   Jiang, Yaqi ^a,b   Wang, Lin ^a   Huang, Na ^a   Lin, Li ^a   Liao, Yulin ^a   Liao, Wangjun ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b YANGZHOU UNIVERSITY   (China)

Author keywords

C Met signaling; Gastric cancer; Lymphangiogenesis; Metastasis associated in colon cancer 1; Vascular endothelial growth factor C D

Indexed keywords

METASTASIS ASSOCIATED IN COLON CANCER 1 PROTEIN; ONCOPROTEIN; RECEPTOR BLOCKING AGENT; REGULATOR PROTEIN; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN C; VASCULOTROPIN D; MACC1 PROTEIN, HUMAN; MACC1 PROTEIN, MOUSE; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER TRANSPLANTATION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL OBSERVATION; COCULTURE; COLON CANCER; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPLORATORY RESEARCH; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR INVASION; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; GENETICS; METABOLISM; METASTASIS; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; STOMACH TUMOR;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 84920415675     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.11.035     Document Type: Article

References (41)

1. Alitalo K., Tammela T., Petrova T.V. Lymphangiogenesis in development and human disease. Nature 2005, 438:946-953.
2. Achen M.G., Stacker S.A. Tumor lymphangiogenesis and metastatic spread-new players begin to emerge. Int. J. Cancer 2006, 119:1755-1760.
3. Wang X.L., Fang J.P., Tang R.Y., Chen X.M. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases. BMC Cancer 2010, 10:299.
4. Iwata C., Kano M.R., Komuro A., Oka M., Kiyono K., Johansson E., et al. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. Cancer Res 2007, 67:10181-10189.
5. Stein U., Walther W., Arlt F., Schwabe H., Smith J., Fichtner I., et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat. Med 2009, 15:59-67.
6. Wang L., Wu Y., Lin L., Liu P., Huang H., Liao W., et al. Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. Int. J. Cancer 2013, 133:1419-1430.
7. Meng F., Li H., Shi H., Yang Q., Zhang F., Yang Y., et al. MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/beta-catenin signaling pathway. PLoS ONE 2013, 8:e60821.
8. Wang Z., Li Z., Wu C., Wang Y., Xia Y., Chen L., et al. MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer. Med. Oncol 2014, 31:790.
9. Lin L., Huang H., Liao W., Ma H., Liu J., Wang L., et al. MACC1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect. Oncogene 2014, 10.1038/onc.2014.204.
10. Guo T., Yang J., Yao J., Zhang Y., Da M., Duan Y. Expression of MACC1 and c-Met in human gastric cancer and its clinical significance. Cancer Cell Int 2013, 13:121.
11. Shirahata A., Fan W., Sakuraba K., Yokomizo K., Goto T., Mizukami H., et al. MACC 1 as a marker for vascular invasive hepatocellular carcinoma. Anticancer Res 2011, 31:777-780.
12. He Y., Rajantie I., Pajusola K., Jeltsch M., Holopainen T., Yla-Herttuala S., et al. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 2005, 65:4739-4746.
13. Burton J.B., Priceman S.J., Sung J.L., Brakenhielm E., An D.S., Pytowski B., et al. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Res 2008, 68:7828-7837.
14. Chang C.H., Huang Y.L., Shyu M.K., Chen S.U., Lin C.H., Ju T.K., et al. Sphingosine-1-phosphate induces VEGF-C expression through a MMP-2/FGF-1/FGFR-1-dependent pathway in endothelial cells in vitro. Acta Pharmacol. Sin 2013, 34:360-366.
15. Xiang L., Xie G., Ou J., Wei X., Pan F., Liang H. The extra domain A of fibronectin increases VEGF-C expression in colorectal carcinoma involving the PI3K/AKT signaling pathway. PLoS ONE 2012, 7:e35378.
16. Chilov D., Kukk E., Taira S., Jeltsch M., Kaukonen J., Palotie A., et al. Genomic organization of human and mouse genes for vascular endothelial growth factor C. J. Biol. Chem 1997, 272:25176-25183.
17. Stein U., Smith J., Walther W., Arlt F. MACC1 controls Met: what a difference an Sp1 site makes. Cell Cycle 2009, 8:2467-2469.
18. Tian M., Yu L., Zhang Y., Gao X. Correlations between SUVmax and expression of GLUT1 and growth factors inducing lymphangiogenesis. Acad. Radiol 2012, 19:420-426.
19. Cao R., Bjorndahl M.A., Gallego M.I., Chen S., Religa P., Hansen A.J., et al. Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood 2006, 107:3531-3536.
20. Kajiya K., Hirakawa S., Ma B., Drinnenberg I., Detmar M. Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J. 2005, 24:2885-2895.
21. Zhao D., Wang S.H., Feng Y., Hua C.G., Zhao J., Tang X.F. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker. Hum. Pathol 2011, 42:1514-1523.
22. Shi M., Huang W., Lin L., Zheng D., Zuo Q., Wang L., et al. Silencing of XB130 is associated with both the prognosis and chemosensitivity of gastric cancer. PLoS ONE 2012, 7:e41660.
23. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med 1991, 324:1-8.
24. Gombos Z., Xu X., Chu C.S., Zhang P.J., Acs G. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Clin. Cancer Res 2005, 11:8364-8371.
25. Rikitake Y., Kawashima S., Yamashita T., Ueyama T., Ishido S., Hotta H., et al. Lysophosphatidylcholine inhibits endothelial cell migration and proliferation via inhibition of the extracellular signal-regulated kinase pathway. Arterioscler. Thromb. Vasc. Biol 2000, 20:1006-1012.
26. Wang J., Guo Y., Zhang B.C., Chen Z.T., Gao J.F. Induction of apoptosis and inhibition of cell migration and tube-like formation by dihydroartemisinin in murine lymphatic endothelial cells. Pharmacology 2007, 80:207-218.
27. Gao P., Zhou G.-Y., Zhang Q.-H., Xiang L., Zhang S.-L., Li C., et al. Clinicopathological significance of peritumoral lymphatic vessel density in gastric carcinoma. Cancer Lett 2008, 263:223-230.
28. Juttner S. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J. Clin. Oncol 2005, 24:228-240.
29. Leelahavanichkul K., Amornphimoltham P., Molinolo A.A., Basile J.R., Koontongkaew S., Gutkind J.S. A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis. Mol. Oncol 2014, 8:105-118.
30. Ozasa R., Ohno J., Iwahashi T., Taniguchi K. Tumor-induced lymphangiogenesis in cervical lymph nodes in oral melanoma-bearing mice. J. Exp. Clin. Cancer Res 2012, 31:83.
31. Maehara Y., Kakeji Y., Koga T., Emi Y., Baba H., Akazawa K., et al. Therapeutic value of lymph node dissection and the clinical outcome for patients with gastric cancer. Surgery 2002, 131:S85-S91.
32. Ran S., Montgomery K.E. Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors. Cancers 2012, 4:618-657.
33. Xie L.X., Zhai T.T., Yang L.P., Yang E., Zhang X.H., Chen J.Y., et al. Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma. Int. J. Exp. Pathol 2013, 94:39-46.
34. Xu Y., Yuan L., Mak J., Pardanaud L., Caunt M., Kasman I., et al. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J. Cell Biol 2010, 188:115-130.
35. Ichise T., Yoshida N., Ichise H. Ras/MAPK signaling modulates VEGFR-3 expression through Ets-mediated p300 recruitment and histone acetylation on the Vegfr3 gene in lymphatic endothelial cells. PLoS ONE 2012, 7:e51639.
36. Su J.L., Yang P.C., Shih J.Y., Yang C.Y., Wei L.H., Hsieh C.Y., et al. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 2006, 9:209-223.
37. Karnezis T., Shayan R., Caesar C., Roufail S., Harris N.C., Ardipradja K., et al. VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell 2012, 21:181-195.
38. Yao J., Da M., Guo T., Duan Y., Zhang Y. RNAi-mediated gene silencing of vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of gastric cancer in vivo in mice. Tumour Biol 2013, 34:1493-1501.
39. Lin W., Jiang L., Chen Y., She F., Han S., Zhu J., et al. Vascular endothelial growth factor-D promotes growth, lymphangiogenesis and lymphatic metastasis in gallbladder cancer. Cancer Lett 2012, 314:127-136.
40. Birchmeier C., Birchmeier W., Gherardi E., Vande Woude G.F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol 2003, 4:915-925.
41. Wang G., Kang M.X., Lu W.J., Chen Y., Zhang B., Wu Y.L. MACC1: a potential molecule associated with pancreatic cancer metastasis and chemoresistance. Oncol. Lett 2012, 4:783-791.